We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · June 15, 2021

Effect of IV Ferric Carboxymaltose on HR-QoL in Iron-Deficient Patients With Acute Heart Failure

European Heart Journal

 

Additional Info

European Heart Journal
The Effect of Intravenous Ferric Carboxymaltose on Health-Related Quality of Life in Iron-Deficient Patients With Acute Heart Failure: The Results of the AFFIRM-AHF Study
Eur Heart J 2021 Jun 03;[EPub Ahead of Print], EA Jankowska, BA Kirwan, M Kosiborod, J Butler, SD Anker, T McDonagh, M Dorobantu, J Drozdz, G Filippatos, A Keren, I Khintibidze, H Kragten, FA Martinez, M Metra, D Milicic, JC Nicolau, M Ohlsson, A Parkhomenko, DA Pascual-Figal, F Ruschitzka, D Sim, H Skouri, P van der Meer, BS Lewis, J Comin-Colet, S von Haehling, A Cohen-Solal, N Danchin, W Doehner, HJ Dargie, M Motro, T Friede, V Fabien, F Dorigotti, S Pocock, P Ponikowski

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading